JAMA Neurology Author Interviews
JAMA Network
Categories: Health
Add to My List
Listen to the last episode:
Previous episodes
-
122 - US Burden of Disorders Affecting the Nervous SystemMon, 24 Nov 2025 - 0h
-
121 - Hemorrhage and Risk Factors in Unruptured Brain AVMMon, 06 Oct 2025 - 0h
-
120 - Intravenous Argatroban or Eptifibatide and Mechanical ThrombectomyMon, 18 Aug 2025 - 0h
-
119 - GLP-1 Receptor Agonists in Idiopathic Intracranial HypertensionMon, 14 Jul 2025 - 0h
-
118 - Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeMon, 02 Jun 2025 - 0h
-
117 - Fremanezumab for the Treatment of Migraine and Major Depressive DisorderMon, 05 May 2025 - 0h
-
116 - Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic StrokeMon, 31 Mar 2025 - 0h
-
115 - Location and Timing of Recurrent, Nontraumatic Intracerebral HemorrhageMon, 03 Mar 2025 - 0h
-
114 - Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With MigraineMon, 06 Jan 2025 - 0h
-
113 - β-Blocker Use and Delayed Onset and Progression of Huntington DiseaseMon, 02 Dec 2024 - 0h
-
112 - Alzheimer Disease as a Clinical-Biological ConstructFri, 01 Nov 2024 - 0h
-
111 - Perceived CTE in Former Professional Football PlayersMon, 23 Sep 2024 - 0h
-
110 - Localized Nicardipine Release Implants for Prevention of VasospasmMon, 19 Aug 2024 - 0h
-
109 - Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic EventsMon, 08 Jul 2024 - 0h
-
108 - Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial FibrillationTue, 28 May 2024 - 0h
-
107 - Association of New-Onset Seizures With SARS-CoV-2 VaccinesMon, 29 Apr 2024 - 0h
-
106 - High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSMon, 25 Mar 2024 - 0h
-
105 - Posttraumatic Epilepsy and Dementia RiskMon, 26 Feb 2024 - 0h
-
104 - Risk of Stroke and Myocardial Infarction Among Initiators of TriptansMon, 05 Feb 2024 - 0h
-
103 - Risk Factors for Young-Onset Dementia in the UK BiobankTue, 26 Dec 2023 - 0h
-
102 - Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large InfarctMon, 27 Nov 2023 - 0h
-
101 - Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisMon, 06 Nov 2023 - 0h
-
100 - Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel DiseaseMon, 30 Oct 2023 - 0h
-
99 - Neuropathologic and Clinical Findings in Athletes With Repetitive Head ImpactsMon, 28 Aug 2023 - 0h
-
98 - Dementia Risk and Disadvantaged NeighborhoodsWed, 19 Jul 2023 - 0h
-
97 - Automated Interpretation of Clinical Electroencephalograms Using Artificial IntelligenceTue, 20 Jun 2023 - 0h
-
96 - Risk of Parkinson Disease Among Camp Lejeune VeteransMon, 15 May 2023 - 0h
-
95 - Prenatal Exposure to Antiseizure Medication and Psychiatric DisordersMon, 17 Apr 2023 - 0h
-
94 - Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk FactorsMon, 27 Mar 2023 - 0h
-
93 - Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic StrokeThu, 23 Feb 2023 - 0h
-
92 - Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known WellTue, 27 Dec 2022 - 0h
-
91 - Autoimmune Encephalitis Misdiagnosis in AdultsMon, 28 Nov 2022 - 0h
-
90 - Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson DiseaseMon, 31 Oct 2022 - 0h
-
89 - Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During PregnancyMon, 26 Sep 2022 - 0h
-
88 - Association of Neurocritical Care With Outcomes for Adults With Brain InjuryMon, 29 Aug 2022 - 0h
-
87 - Efficacy of Benzodiazepines or Antihistamines for Patients With Acute VertigoMon, 18 Jul 2022 - 0h
-
86 - A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in ChiefTue, 05 Jul 2022 - 0h
-
85 - Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the USMon, 27 Jun 2022 - 0h
-
84 - Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual DisabilityTue, 31 May 2022 - 0h
-
83 - Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19Mon, 11 Apr 2022 - 0h
-
82 - Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain InjuryMon, 21 Feb 2022 - 0h
-
81 - Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin EfficacyTue, 18 Jan 2022 - 0h
-
80 - Assessment of Erenumab Safety and Efficacy in Migraine With and Without AuraMon, 20 Dec 2021 - 0h
-
79 - Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy BodiesMon, 22 Nov 2021 - 0h
-
78 - Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-upMon, 18 Oct 2021 - 0h
-
77 - Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody EncephalitisMon, 20 Sep 2021 - 0h
-
76 - Risk of Rupture After Intracranial Aneurysm GrowthMon, 30 Aug 2021 - 0h
-
75 - Seizure Prophylaxis After Spontaneous Intracerebral HemorrhageMon, 26 Jul 2021 - 0h
-
74 - Tau PET as a Prognostic MarkerMon, 28 Jun 2021 - 0h
-
73 - Association of Nitrogen Dioxide and Other Air Pollution Exposures With the Risk of Parkinson DiseaseMon, 17 May 2021 - 0h
Show more episodes
5
